Skip survey header

2018 Clinical Conference Evaluation & Post Test-Enduring Materials Format: Pathology Update for the PCP


May 15, 2018 - Evaluation - Pathology Update for the PCP, Presented by: Barry Latner, MD
Estimated Time to complete the activity is 45 minutes. Activity and content expires: May 15, 2021
Statement of disclosure: The planners and faculty for this activity have no relevant financial relationships with commercial interests. No others individuals involved in the planning or presentation of this activity have any relevant financial relationships with commercial interests to disclose.
Accreditation Statement: John Muir Health is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.
Credit Designation Statement: John Muir Health designates this enduring material for a maximum of one (.75) AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
Minimum level of achievement:   Must score 75% correct on posttest and complete the statement of how you will improve your practice after participation is mandatory.
JMH Internet Policy:
Please complete and return this evaluation form in order to receive a maximum of .75 AMA PRA Category 1 Credit™ for this session
1. Physician Info
This question requires a valid date format of MM/DD/YYYY.
3. As a result of attending this CME activity, which of these do you plan to implement and/or change in your practice? *This question is required.
Space Cell DefinitelyMaybeNo Change
Differentiate between older and newer options for Laboratory testing.
Formulate and communicate treatment plans for the management of medically and socially complex patients
Apply best practice strategies to overcome co-morbidities in medically and socially complex patients
Apply tips and tricks for navigating Epic.
Utilize EBM Guidelines for a multitude of conditions that are encountered in primary care
Utilize Patient Centered Care skill to help patients become better informed and more involved in their health care decisions.
9. Was their evidence of commercial bias in this session? ​
10. The test of choice for vitamin D status is:
11. D-dimer is best used in the context of the pretest probability of DVT/PE?
12. Which of the following is false regarding D-dimer?
13. Biotin in very high doses can interfere with lab tests that utilized biotin-streptavidin technology, such as TSH, cTnI,  NT-proBNP, and iPTH?